Pancreatic Cancer Research

ResearcherYanbian UniversityNo recent work listed

Jie Lena Sun

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8368-3091; OpenAlex author ID A5006174888. Sources: OpenAlex.

Their work

Papers
4 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2017: 2 papers · 2018: none · 2019: 2 papers

Papers 4

  1. High expression of CDK1 and BUB1 predicts poor prognosis of pancreatic ductal adenocarcinoma. Co-author DOI 10.1016/j.gene.2019.02.081↗
  2. Ezrin promotes pancreatic cancer cell proliferation and invasion through activating the Akt/mTOR pathway and inducing YAP translocation. First author DOI 10.2147/cmar.s202342↗
  3. Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma. Co-author DOI 10.3892/ol.2017.5821↗
  4. DEK protein overexpression predicts poor prognosis in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/or.2016.5302↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Junjie Piao · 2 shared papers, 2019 · strength 0.21
  2. Liyan Chen · 2 shared papers, 2017–2019 · strength 0.18
  3. Aihua Jin · 2 shared papers, 2017 · strength 0.15
  4. Zhenhua Lin · 2 shared papers, 2017 · strength 0.15
  5. Chunji Quan · 1 shared paper, 2019 · strength 0.11
  6. Zhenhua Lin · 1 shared paper, 2019 · strength 0.11
  7. Meiying Ji · 1 shared paper, 2017 · strength 0.08
  8. Yang Yang · 1 shared paper, 2017 · strength 0.08
  9. Xuelian Cui · 1 shared paper, 2017 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.